JCB logo
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 571K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matter, M. L.
Right arrow Articles by Ruoslahti, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matter, M. L.
Right arrow Articles by Ruoslahti, E.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

© The Rockefeller University Press, 0021-9525/1998//1019 $5.00
The Journal of Cell Biology, Volume 141, Number 4, , 1998 1019-1030

Articles

The {alpha}5β1 Integrin Mediates Elimination of Amyloid-β Peptide and Protects Against Apoptosis



Michelle L. Matter*, Zhuohua Zhang*,{ddagger}, Christer Nordstedt§, and Erkki Ruoslahti*

* La Jolla Cancer Research Center, The Burnham Institute, La Jolla, California 92037; {ddagger} Department of Neurobiology, Harvard Medical School, and Division of Neuroscience, The Children's Hospital, Boston, Massachusetts 02115; and § Department of Clinical Neuroscience, The Karolinska Hospital, Stockholm, Sweden S-171 76

The amyloid-β peptide (Aβ) can mediate cell attachment by binding to β1 integrins through an arg-his-asp sequence. We show here that the {alpha}5β1 integrin, a fibronectin receptor, is an efficient binder of Aβ, and mediates cell attachment to nonfibrillar Aβ. Cells engineered to express {alpha}5β1 internalized and degraded more added Aβ1-40 than did {alpha}5β1-negative control cells. Deposition of an insoluble Aβ1-40 matrix around the {alpha}5β1-expressing cells was reduced, and the cells showed less apoptosis than the control cells. Thus, the {alpha}5β1 integrin may protect against Aβ deposition and toxicity, which is a course of Alzheimer's disease lesions.

Abbreviations used in this paper: Aβ, amyloid β peptide; AD, Alzheimer's disease, LDH, lactate dehydrogenase; RHD, arg-his-asp.

The present address of Z. Zhang is Department of Neurobiology, Harvard Medical School, The Children's Hospital, Enders 260, 300 Longwood Ave., Boston, MA 02115.

Address all correspondence to Erkki Ruoslahti, The Burnham Institute, 10901 North Torrey Pines Rd., La Jolla, CA 90237. Tel.: 619-646-3125; Fax: 619-646-3199; E-mail: ruoslahti{at}burnham-inst.org


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents